MTACU has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MTACU has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
MedTech Acquisition's Total Assets for the quarter that ended in Jun. 2023 was $12.24 Mil.
During the past 12 months, MedTech Acquisition's average Total Assets Growth Rate was -95.20% per year.
Total Assets is connected with ROA %. MedTech Acquisition's annualized ROA % for the quarter that ended in Jun. 2023 was -24.30%. Total Assets is also linked to Revenue through Asset Turnover. MedTech Acquisition's Asset Turnover for the quarter that ended in Jun. 2023 was 0.00.
The historical data trend for MedTech Acquisition's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedTech Acquisition Annual Data | |||||||
Trend | Dec20 | Dec21 | Dec22 | ||||
Total Assets | 252.01 | 250.53 | 20.19 |
MedTech Acquisition Quarterly Data | ||||||||||||
Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | |
Total Assets | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
250.56 | 251.33 | 20.19 | 20.52 | 12.24 |
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
MedTech Acquisition's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as
Total Assets | = | Total Equity (A: Dec. 2022 ) | + | Total Liabilities (A: Dec. 2022 ) |
= | 6.533 | + | 13.654 | |
= | 20.19 |
MedTech Acquisition's Total Assets for the quarter that ended in Jun. 2023 is calculated as
Total Assets | = | Total Equity (Q: Jun. 2023 ) | + | Total Liabilities (Q: Jun. 2023 ) |
= | -3.074 | + | 15.312 | |
= | 12.24 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedTech Acquisition (NAS:MTACU) Total Assets Explanation
Total Assets is connected with ROA %.
MedTech Acquisition's annualized ROA % for the quarter that ended in Jun. 2023 is
ROA % | = | Net Income (Q: Jun. 2023 ) | / | ( (Total Assets (Q: Mar. 2023 ) | + | Total Assets (Q: Jun. 2023 )) | / count ) |
= | -3.98 | / | ( (20.52 | + | 12.238) | / 2 ) | |
= | -3.98 | / | 16.379 | ||||
= | -24.30 % |
Note: The Net Income data used here is four times the quarterly (Jun. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
MedTech Acquisition's Asset Turnover for the quarter that ended in Jun. 2023 is
Asset Turnover | ||||||
= | Revenue (Q: Jun. 2023 ) | / | ( (Total Assets (Q: Mar. 2023 ) | + | Total Assets (Q: Jun. 2023 )) | / count ) |
= | 0 | / | ( (20.52 | + | 12.238) | / 2 ) |
= | 0 | / | 16.379 | |||
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Thank you for viewing the detailed overview of MedTech Acquisition's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Magnetar Financial Llc | 10 percent owner | 1603 ORRINGTON AVE., 13TH FLOOR, EVANSTON IL 60201 |
Magnetar Capital Partners Lp | 10 percent owner | 1603 ORRINGTON AVE., 13TH FLOOR, EVANSTON IL 60201 |
Supernova Management Llc | 10 percent owner | 1603 ORRINGTON AVENUE, 13TH FLOOR, EVANSTON IL 60201 |
David J. Snyderman | 10 percent owner | C/O MAGNETAR FINANCIAL LLC, 1603 ORRINGTON AVENUE, 13TH FLOOR, EVANSTON IL 60201 |
David L Treadwell | director | 222 S 15TH STREET, SUITE 600 N, OMAHA NE 68102 |
Manuel Aguero | director | 600 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10022 |
Thierry B. Thaure | director | 3957 POINT EDEN WAY, HAYWARD CA 94545 |
David J Matlin | director, 10 percent owner, officer: Chief Financial Officer | |
Karim Karti | director | C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 500, SAN FRANCISCO CA 94103 |
Christopher C Dewey | director, 10 percent owner, officer: Chief Executive Officer | 120 BROADWAY, 27TH FLOOR, NEW YORK NY 10271 |
Robert H. Weiss | officer: Chief Admin Officer and Sec. | 585 WEED STREET, NEW CANAAN CT 06840 |
Maurice R Ferre | director | C/O MAKO SURGICAL CORP., 2555 DAVIE ROAD, FORT LAUDERDALE FL 33317 |
Ivan Delevic | director | C/O MAKO SURGICAL CORP., 2555 DAVIE ROAD, SUITE 110, FORT LAUDERDALE FL 33317 |
Medtech Acquisition Sponsor Llc | 10 percent owner | 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105 |
Martin William Roche | director | 600 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10022 |
From GuruFocus
By PRNewswire PRNewswire • 08-13-2021
By GuruFocus Research • 08-15-2023
By PRNewswire PRNewswire • 01-06-2022
By Business Wire Business Wire • 02-21-2023
By Business Wire Business Wire • 06-12-2023
By GuruFocusNews GuruFocusNews • 03-10-2022
By PRNewswire PRNewswire • 09-09-2021
By Marketwired Marketwired • 06-02-2021
By Marketwired Marketwired • 12-23-2020
By GlobeNewswire GlobeNewswire • 12-22-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.